Pacira Sues FDA Over Constraints On Pain Drug's Marketing
Pacira Pharmaceuticals Inc. on Tuesday filed a lawsuit against the U.S. Food and Drug Administration claiming the agency's unilateral attempt to quash the company's off-label marketing for pain medication Exparel violated...To view the full article, register now.
Already a subscriber? Click here to view full article